News & Analysis on Clinical Trial Services & Contract Research And Development
According to a new report, the costs of clinical development are rising more rapidly in relation to the other parts of the R&D process, placing greater emphasis on the recruitment of test subjects, as clinical trial service providers become...
Lonza has scored a manufacturing contract to help Bristol Myers-Squibb (BMS) meet anticipated demand of its newly approved drug that will offer a new treatment option for rheumatoid arthritis, a disease that afflicts more than two million Americans.
The expiration of the Polymerase Chain Reaction (PCR) patent is set to offer growth opportunities for nucleic acid purification and amplification technologies, particularly for small companies, who can offer tests without developing a novel nucleic...
Ventiv's Clinical Services division has joined with India's largest domestic contract research organization (CRO), SIRO Clinpharm, to provide India-based clinical data management services, offering pharma and biotech companies a cost-effective...
Research undertaken by Nastech has uncovered that endothelial tight junctions play a role in atherosclerosis, which may provide new therapeutic targets for cardiovascular disease.
With two acquisitions in two months, US biotechnology major Genzyme has strengthened and diversified its ability to develop gene therapy products that use either adenovirus or adeno-associated virus vectors.
Leading contract research organisation, Covance, has upgraded its software to streamline the laboratory testing aspect of its clinical trials and allow sponsoring drug companies greater involvement in the overall process.